An open-label, single-arm, phase 2 study of single-agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomib (Q34291281)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An open-label, single-arm, phase 2 study of single-agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomib |
scientific article |
Statements
1 reference
An open-label, single-arm, phase 2 study of single-agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomib (English)
1 reference
Andrzej J Jakubowiak
1 reference
Ravi Vij
1 reference
David S Siegel
1 reference
Sundar Jagannath
1 reference
Alexander Keith Stewart
1 reference
Kevin McDonagh
1 reference
Nizar Bahlis
1 reference
Andrew Belch
1 reference
Lori A Kunkel
1 reference
Sandra Wear
1 reference
Alvin F Wong
1 reference
Michael Wang
1 reference
30 July 2012
1 reference
1 reference
158
1 reference
6
1 reference
739-748
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference